Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Early Detection for Alzheimer's, Chronic Fatigue Syndrome and Other Diseases

Abstract:
In Vitro Diagnostic Tests from Neuro-Biotech Corp. to a Doctor Near You!

Early Detection for Alzheimer's, Chronic Fatigue Syndrome and Other Diseases

Basel, Switzerland | Posted on September 20th, 2010

Neuro-Biotech Corporation (PINKSHEETS: MRES)(OTCQB: MRES) is a worldwide biotechnological enterprise involved in the unique international niche of clinical neuroscience diagnostic testing. Neuro-Biotech Corp. uses proprietary molecular nanotechnology IVDDs (in vitro diagnostic devices) for the quantitative measurement of blood parameters to evaluate the input and output of the brain through specific neuro-biomarkers. As a result of more than 20 years of R&D, Neuro-Biotech Corp.'s specific expertise in clinical neurosciences applied enzymology is dedicated to the understanding of the relationship between the neurotransmitter families within the brain and their various influences on the peripheral systems involving the Hypothalamo-Pituitary Adreno-Sympathetic (HPAS) Axis. The HPAS Axis manages body mechanisms against stressful situations in order to maintain the homeostasis responsible for the resistance of the organism to its psycho-socio-environment through psycho-neuro-immune and endocrine systems.

This unique understanding of the communication between the brain and the human body, has led to the development of in vitro diagnostic blood tests. They are used for the detection, prevention, monitoring and follow-up of the major stress-related, socio-professional and occupational diseases, such as Chronic Fatigue Syndrome (CFS), Great Anxiety (GA), Panic Syndrome (PS), Neuropathies or Fibromyalgia (FM), Cardiovascular diseases like Essential Hypertension or Arrhythmia, Neurodegenerative diseases such as Alzheimer and Parkinson Diseases as well as Mental-Health Disorders in the vein of Depression and Schizophrenia.

Neuro-Biotech Corp's goals have resulted in a new and reliable portfolio of quantitative blood tests that provide general practitioners and specialists useful clinical parameters for the diagnosis of neuroscience-related diseases or physio-pathological impairments. This is accomplished by identifying abnormal readings of specific bio-markers within the blood or other biological fluids. Neuro-Biotech Corp's diagnostic tests are without equal in being non-invasive, sensitive, reliable and rapidly done as an essential complement to current clinical laboratory testing procedures.

Neuro-Biotech presently has the opportunity to commercialize 12 clinical Neuro Blood Tests through partnerships, as specialized blood testing for a progressive clinical neuroscience investigation of targeted diseases, thus selectively monitoring specific neuro-biomarkers related to the neuro-immune and endocrine systems. Caregivers will now be able to evaluate and establish an individual's ability to react to stress and, to identify the appropriate neuro-endocrine and immune dysfunctioning. By monitoring bio-indicators related to workplace stress-related diseases and mental-health disorders, efficient patient treatment and follow-up are feasible.

Forward Looking Statements

This release contains statements that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Act of 1995. Certain statements in this press release may contain words such as "anticipates," "believes," "could," "expects," "intends," "may," "projects," "targets" and other similar language that is considered forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties and persons reading this release are cautioned that such statements are only predictions, and that the Company's actual future results or performance may be materially different. The Company disclaims any intention or obligation to update or revise forward-looking information, whether as a result of new information, future events, or otherwise, could cause the company's actual results to differ materially from those indicated in any forward-looking statements.

####

For more information, please click here

Contacts:

Copyright © Neuro-Biotech Corp.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Evidence mounts for quantum criticality theory: Findings bolster theory that quantum fluctuations drive strange electronic phenomena January 30th, 2015

Everything You Need To Know About Nanopesticides January 30th, 2015

DNA nanoswitches reveal how life's molecules connect: An accessible new way to study molecular interactions could lower cost and time associated with discovering new drugs January 30th, 2015

Crystal light: New light-converting materials point to cheaper, more efficient solar power: University of Toronto engineers study first single crystal perovskites for new solar cell and LED applications January 30th, 2015

Nanomedicine

DNA nanoswitches reveal how life's molecules connect: An accessible new way to study molecular interactions could lower cost and time associated with discovering new drugs January 30th, 2015

Made-in-Singapore rapid test kit detects dengue antibodies from saliva: IBN's MedTech innovation simplifies diagnosis of infectious diseases January 29th, 2015

Iranian Researchers Planning to Produce Edible Insulin January 28th, 2015

Nanoparticles that deliver oligonucleotide drugs into cells described in Nucleic Acid Therapeutics January 28th, 2015

Announcements

Evidence mounts for quantum criticality theory: Findings bolster theory that quantum fluctuations drive strange electronic phenomena January 30th, 2015

Everything You Need To Know About Nanopesticides January 30th, 2015

DNA nanoswitches reveal how life's molecules connect: An accessible new way to study molecular interactions could lower cost and time associated with discovering new drugs January 30th, 2015

Crystal light: New light-converting materials point to cheaper, more efficient solar power: University of Toronto engineers study first single crystal perovskites for new solar cell and LED applications January 30th, 2015

Nanobiotechnology

DNA nanoswitches reveal how life's molecules connect: An accessible new way to study molecular interactions could lower cost and time associated with discovering new drugs January 30th, 2015

Spider electro-combs its sticky nano-filaments January 28th, 2015

Nanoshuttle wear and tear: It's the mileage, not the age January 26th, 2015

Engineering self-assembling amyloid fibers January 26th, 2015

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2015 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE